Home Page
The latest articles, features and news.



Read About...

Adolescence
AIDS/HIV Treatments
Andropause
Assisted Reproduction
Circumcision
Dating
Dicks & History
Enlargement
Fertility
Firefly Talks Dicks
Gay and Bi
Gender
Getting It Up
Male Peculiarities
Paternity
Pecker Problems
Penis Size
Prostate Cancer
Relationships
STDs


Search Articles

Custom Search



Discussion Forums


Q and A
Sexuality
Dating
Size
Pics





1 March 2010
Experimental treatment hits the toughest prostate cancer cells
by George Atkinson

For more than fifty years, one of the main ways to treat men with prostate cancer has involved removing the hormones that fuel growth of the cancer cells. Although initially effective, this treatment inevitably fails and when the tumor growth resumes, the disease becomes incurable.

Now, a team of scientists from Monash University, Australia, has found a way to kill off those cancer cells that are resistant to androgen deprivation therapy. Appearing in the medical journal PNAS, the new work provides proof for the controversial concept that estrogens can be used therapeutically to treat prostate cancer.

"Most commonly cell death in patients with prostate cancer is achieved by withdrawing androgens (male hormones) which results in castration," said Monash's Gail Risbridger. "Although the bulk of the tumor is removed by castration, some cells remain and these castrate-resistant cells are the ones that give rise to recurrent incurable disease."

In the new research, the team used a drug developed to selectively and specifically activate the beta estrogen receptor in the prostate. "It not only inhibits the growth of prostate cancer but also kills off cancer cells that are resistant to conventional treatment such as androgen deprivation therapy and does so using a mechanism that is different to castration," Risbridger explained.

The team made the discovery in animal models, and then successfully replicated laboratory results using human cells and tissues from patients with prostate cancer. "[We] discovered how this compound working through the beta receptors targets a small, but very important, population of cells in the tumor. It is a significant piece of the puzzle that will help medical research in this field - an achievement that could eventually enhance treatment options for patients around the world with advanced prostate cancer," Risbridger said.

Related:
Heart problems exacerbated with hormonal prostate treatment
Prostate Cancer Drugs Found To Addle The Brain
Prostate Cancer Cells Can "Fuel" Themselves
Prostate Cancer Hormone Treatment Brings Own Set Of Health Risks

Source: Monash University




Home Page    Contact Us    Privacy


Your use of this website indicates your agreement to our terms and conditions of use.
Copyright 2000 - 2012 altPenis.com and its licensors. All rights reserved.